Catheter Precision, Inc.
VTAK
$0.30
-$0.0262-8.03%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 74.39% | 16.41% | -27.82% | -3.13% | -3.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 74.39% | 16.41% | -27.82% | -3.13% | -3.53% |
| Cost of Revenue | 120.00% | 57.14% | 66.67% | 128.57% | -50.00% |
| Gross Profit | 71.43% | 14.05% | -32.28% | -13.48% | 2.67% |
| SG&A Expenses | 31.21% | 13.52% | 4.99% | 91.73% | -74.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.40% | 17.43% | 3.21% | 80.59% | -74.26% |
| Operating Income | -32.11% | -17.48% | -4.73% | -86.10% | 74.84% |
| Income Before Tax | -78.28% | -271.75% | -113.80% | -167.77% | 95.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -51.21% | -741.26% | -113.80% | -167.77% | 95.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.21% | -741.26% | -113.80% | -167.77% | 95.97% |
| EBIT | -32.11% | -17.48% | -4.73% | -86.10% | 74.84% |
| EBITDA | -39.68% | -21.15% | -5.38% | -348.98% | 76.61% |
| EPS Basic | 90.04% | -19.54% | 29.05% | -89.66% | 98.54% |
| Normalized Basic EPS | 88.55% | 72.44% | 29.05% | -191.35% | 90.48% |
| EPS Diluted | 90.04% | -19.54% | 29.05% | -89.66% | 98.54% |
| Normalized Diluted EPS | 88.55% | 72.44% | 29.05% | -191.35% | 90.48% |
| Average Basic Shares Outstanding | 1,418.90% | 1,248.63% | 201.34% | 41.18% | 172.52% |
| Average Diluted Shares Outstanding | 1,418.90% | 1,248.63% | 201.34% | 41.18% | 172.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |